Bio-Techne (TECH) FCF Margin (2009 - 2026)

Bio-Techne's FCF Margin history runs 18 years deep, the most recent figure standing at 24.91% for Q1 2026.

• On a quarterly basis, FCF Margin rose 1511.0% year-over-year to 24.91% in Q1 2026; TTM through Mar 2026 was 22.27%, a 400.0% increase from a year earlier, with the FY2025 full-year figure at 21.03%, up 66.0% from the prior year.
• FCF Margin fell to 24.91% in Q1 2026 per TECH's latest filing, from 25.85% in the prior quarter.
• Across five years, FCF Margin topped out at 2326.25% in Q3 2022 and bottomed at 7.75% in Q3 2025.
• The 5-year median for FCF Margin is 21.46% (2022), against an average of 156.49%.
• Across the five-year window, FCF Margin soared 230981 bps in 2022 and tumbled 230972 bps in 2023, its largest moves.
• Year by year, FCF Margin stood at 21.46% in 2022, then increased by 17 bps to 25.04% in 2023, then climbed by 4 bps to 26.1% in 2024, then slipped by 1 bps to 25.85% in 2025, then declined by 4 bps to 24.91% in 2026.
• Per Business Quant, the three latest TECH FCF Margin figures stand at 24.91% (Q1 2026), 25.85% (Q4 2025), and 7.75% (Q3 2025).